Description
THALOMID 50MG PATIENT STUDIES WRJ
First action · last action
2012-01-19 · 2012-01-19
Transactions
1
First transaction's obligation
$25,370
Base + all options value (sum of deltas)
$25,370
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-01-19+$25,370= $25,370
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-01-19 | +$25,370 | $25,370 | THALOMID 50MG PATIENT STUDIES WRJ |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI VMJLFQE5U511)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24225P1011 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $4,853 | FY2025 |
| 36C24825P0474 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $11,859 | FY2025 |
| 36C25024P1401 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $16,500 | FY2024 |
| 36E79724D0028 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C25024P0630 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $20,786 | FY2024 |
| 36C25024P0413 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $5,196 | FY2024 |
Other recipients under 6505 from 241-NETWORK CONTRACT OFFICE 01 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24116J0881 | SANOFI VACCINES US INC. | 241-NETWORK CONTRACT OFFICE 01 | $61,770 | FY2016 |
| VA24116P0956 | MCKESSON PLASMA AND BIOLOGICS LLC | 241-NETWORK CONTRACT OFFICE 01 | $12,541 | FY2016 |
| VA24116P0929 | JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. | 241-NETWORK CONTRACT OFFICE 01 | $14,960 | FY2016 |
| VA24116J0926 | EXELIXIS, INC. | 241-NETWORK CONTRACT OFFICE 01 | $6,941 | FY2016 |
| VA24116J0870 | CSL BEHRING L.L.C. | 241-NETWORK CONTRACT OFFICE 01 | $413 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24112P0470_3600_-NONE-_-NONE- · retrieved 2026-09-26.